< Back to Newsletter Archive

BIO Newsletter
BIO Newsletter: Different Perspectives for AHIP to Consider During Today’s Discussion on Drug Costs
SUBSCRIBE | VIEW ONLINE 03.08.2018
BIO NEWSLETTER
Providing Critical Information About the Industry
VISIT BIO.ORG
Different Perspectives for AHIP to Consider During Today’s Discussion on Drug Costs
Today, America’s Health Insurance Plans, or AHIP, is hosting its annual health policy conference. Included in the two-day event is a discussion entitled, “Industry Perspectives on Where We Go from Here on Drug Pricing.” Judging from the panelists, it seems the only perspective AHIP is willing to consider is one that aligns with its own views on this important topic...
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Secretary Azar Talks Opioid Strategy with NGA
HEALTH
spacer
Reps. Upton and Dingell on Solving America’s Opioid Crisisarrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO International Convention
spacer
BIO 2018
Registration Now Openarrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO 2018
Double border
Drug Cost Facts Double border
HEALTH HEALTH
Preparing for the Next Public Health Emergency
Last week, former Senator Joe Lieberman (D-Conn) and former Governor Tom Ridge (R-PA) authored a powerful opinion in The Hill on the importance of budgeting for the next public health emergency that "could kill more people than nuclear war."
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH HEALTH
Secretary Azar Talks Opioid Strategy with NGA
Recently, HHS Secretary Alex Azar joined the National Governors Association to discuss opioid addiction and abuse in America. While we can all agree that there is no silver bullet to solving this problem, Secretary Azar outlined several proposals – consistent with recommendations BIO recently released – that the public and private sectors can take to help prevent opioid use disorders in current and future generations...
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH HEALTH
BIO Applauds Introduction of the Ensuring the Value of the 340B Program Act of 2018
BIO applauds Senator Grassley for introducing reforms that would provide much-needed clarity for lawmakers and the public on how hospitals are profiting from the 340B Drug Discount Program. Congress created the program to help uninsured and vulnerable patients gain access to affordable prescription drugs. However, the evidence is now undeniable that this program has expanded well beyond the intent of Congress and that patients are not seeing the benefits they deserve...
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Food & Ag Food & Agriculture
Local Government Bans GM Crops to Decrease Pesticide Use While County Continues to Use Pesticide
The use of fearmongering around genetically modified crops by the organic industry has led to ballot initiatives in several states and counties looking to ban the technology...
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Food & Ag Food & Agriculture
Bill Gates Calls GMOs 'Perfectly Healthy' – And Scientists Say He's Right
Bill Gates has a message for those advocating against genetically modified organisms: I’m disappointed. Business Insider science correspondent Erin Brodwin explains…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Food & Ag BIO HISTORY
BIO at 25 – A View of the Past; a Glimpse into the Future
In recognition of BIO’s 25th anniversary, BIO CEO and President, Jim Greenwood sat down with two early champions to talk about what triggered the formation of the organization and what we can learn from the past to help shape the future. That future is envisioned by BIO’s current chair, Dr. John Maraganore in a third video...
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
HEALTH BIO International Convention
International Women’s Day: Highlighting Women Pioneers in Science & Medicine
In honor of International Women’s Day, we’re highlighting the work of two leaders and pioneers in healthcare—Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation, and Penny Heaton, CEO of the Bill & Melinda Gates Medical Research Institute..
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Bio Jobs
©2018 Biotechnology Innovation Organization. All rights reserved.
About BIO | Privacy Policy | Terms of Use | Subscribe | Unsubscribe | Feedback | Advertising
FOLLOW US: Follow us on Facebook Follow us on Twitter Follow us on LinkedIn Email us